Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions
Brief summary
Children’s instrumental responding to caregiver-related cues compared to neutral cues; children’s trust learning and support-seeking behavior; behavioral-based rating of children’s attachment representations and parental sensitivity; immediate affective relationship dynamics.
Interventions
DRUGDescription: White
DRUGround
DRUGflat
DRUGwith beveled edges. One side bears the imprint "CG"
DRUGthe other “A/B" and score. May contain dark specks. Diameter: about 7.0 mm.Thickness: about 2.6 mm.
Composition:
Ingredient Amount per tablet [mg] Function Reference
Wheat starch 51
DRUG69 Diluent
DRUGBinder
DRUGDisintegrant Ph. Eur.
Lactose
DRUGmonohydrate 43
DRUG08 Diluent Ph. Eur.
Calcium phosphate
DRUGtribasic 37
DRUG69 Diluent Ph. Eur.
Water
DRUGpurified1 - - Ph. Eur.
Talc 6
DRUG03 Glidant Ph. Eur.
Gelatin 1
DRUG08 Binder Ph. Eur.
Magnesium stearate 0
DRUG43 Lubricant Ph. Eur.
Total weight 140
DRUG0
Packaging: PA/AL/PVC blister pack backed with a heat-sealable lacquered aluminum foil.
The manufacturing process of the tablets consists of a traditional wet granulation process which is carried out according to standard pharmaceutical procedures of wetting
DRUGmassing/kneading
DRUGdrying
DRUGsieving
DRUGmixing and tableting.
DRUGRilatine 10 mg Tabletten
Sponsors
UZ Leuven
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Children’s instrumental responding to caregiver-related cues compared to neutral cues; children’s trust learning and support-seeking behavior; behavioral-based rating of children’s attachment representations and parental sensitivity; immediate affective relationship dynamics. | — |
Outcome results
None listed